Cleared Traditional

K980574 - AURAFLEX TSH-3 200 TEST PACK MODEL NUMBER 80600, AURAFLEX TSH-3 CALIBRATOR PACK MODEL NUMBER NUMBER 80601 AURAFLEX DIL0

K980574 is an FDA 510(k) clearance for AURAFLEX TSH-3 200 TEST PACK MODEL NUMB..., manufactured by Alfa Biotech (Uk) , Ltd.. The device is a Class 2 Chemistry device with product code JLW cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K980574 · Alfa Biotech (Uk) , Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1998
Decision
35d
Days
Class 2
Risk

K980574 is an FDA 510(k) clearance for the AURAFLEX TSH-3 200 TEST PACK MODEL NUMBER 80600, AURAFLEX TSH-3 CALIBRATOR P.... Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by Alfa Biotech (Uk) , Ltd. (Aldershot, GB). The FDA issued a Cleared decision on March 24, 1998 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1690 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Alfa Biotech (Uk) , Ltd. devices

FDA 510(k) Submission Details - K980574

510(k) Number K980574 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 1998
Decision Date March 24, 1998
Days to Decision 35 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 88d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JLW Device Classification - Class 2, Special Controls

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 195
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K980574.
ABBOTT ARCHITECT TSH
K983442 · Abbott Laboratories · Nov 1998
3RD GENERATION TSH ASSAY FOR THE BAYER IMMUNO 1 SYSTEM
K981312 · Bayer Corp. · Jun 1998
ABBOTT AXSYM 3RD GENERATION TSH ASSAY
K981060 · Abbott Laboratories · Apr 1998
AUTODELFIA NEONATAL HTSH L KIT (B077-112)
K973276 · Eg &G Wallac · Nov 1997
AIA-PACK TSH 3RD-GEN ASSAY
K972586 · Tosoh Medics, Inc. · Aug 1997
THYROTROPIN(TSH) ELISA
K971780 · Monobind · Jun 1997